Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00672672|
Recruitment Status : Terminated (Study closed with no subjects accrued. PI decided to stop study.)
First Posted : May 6, 2008
Last Update Posted : August 3, 2011
|Condition or disease||Intervention/treatment||Phase|
|Wounds Infection||Biological: autologous platelet gel||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||250 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients|
|Study Start Date :||February 2009|
|Estimated Primary Completion Date :||July 2012|
Patients who do not receive platlet gel.
Biological: autologous platelet gel
Patients will receive APG to the surgical site in the operating room. The control site will receive no treatment.
- The surgical sites will be assessed for degree of healing and signs and symptoms of infection on postop days one and three and during the patients' follow up visits in the clinic. [ Time Frame: 30 days ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00672672
|United States, Nebraska|
|University of Nebraska Medical Center|
|Omaha, Nebraska, United States, 68198|